COMMUNIQUÉS West-GlobeNewswire

CVRx Announces Positive News on Outpatient Payment for Barostim
16/07/2025
MINNEAPOLIS, July 16, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services (CMS) has proposed to [...]
Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism
16/07/2025
CELEBRATION, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, [...]
Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call
16/07/2025
DURHAM, N.C., July 16, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its second quarter 2025 financial [...]
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach
16/07/2025
- New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s wholly-owned Alzheimer’ [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/07/2025
WATERTOWN, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]
Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products
16/07/2025
WARSAW, Ind., July 16, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced a [...]
Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis
16/07/2025
-- Expanded funding builds on the initial agreement to accelerate development of Prime Editors for Cystic Fibrosis (CF) -- -- Prime Medicine to receive up to $24 million in additional funding from the Cystic Fibrosis [...]
Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment
16/07/2025
Collaboration focuses on the discovery of novel, non-CRBN/VHL, Targeted Glue™ degraders for oncology and immunology indications Cambridge, UK, 16 July 2025 – Amphista Therapeutics (“the Company” or “Amphista”), a leader [...]
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025
16/07/2025
Company Announcement Net sales of DARZALEX ® in the second quarter of 2025 totaled USD 3,539 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, [...]
La nouvelle science des superhumains : le système d’IA BioSport™ libère le potentiel caché des athlètes
16/07/2025
Grâce à des conseillers d’élite, à une génomique de pointe et à une IA en temps réel, la plateforme de santé sportive cible les complications cardiaques, les blessures dues au surmenage, les sélections d’équipe [...]
Evox Therapeutics Expands Scientific Advisory Board
16/07/2025
Additional world-leading expertise stands to further accelerate the Company’s pipeline programs targeting rare neurodegenerative diseases OXFORD, United Kingdom, July 16, 2025 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd [...]
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
16/07/2025
Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit two key complement [...]
Communiqué de presse : Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge
16/07/2025
Le SAR446597 de Sanofi a obtenu la désignation « fast track » aux États-Unis pour le traitement de l’atrophie géographique liée à la dégénérescence maculaire liée à l’âge Cette désignation a été obtenue pour une [...]
Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility
16/07/2025
Beijing, China, July 15, 2025 (GLOBE NEWSWIRE) -- Jin Medical International Ltd. (Nasdaq: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a Nasdaq-listed provider of rehabilitation medical [...]
Barrett Family Foundation Makes Historic Gift to Help Build Extraordinary in Healthcare
16/07/2025
TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- In a defining moment for healthcare, the Barrett Family Foundation has made a transformative donation to St. Joseph’s Health Centre—part of Unity Health Toronto—to create the [...]
Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th
15/07/2025
Company to announce improvements in Margins, Operational Efficiency, and a shift to positive Adjusted EBITDA REDWOOD CITY, Calif., July 15, 2025 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), an innovative Technology [...]
Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML
15/07/2025
SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple [...]
Gain Therapeutics Announces Proposed Public Offering
15/07/2025
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]
ADR Ratio Change
15/07/2025
July 15, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a pipeline [...]

Pages